Corporate Action – ASCELIA

All All press releases Regulatory press releases Financial reports

2024-10-01 | Ascelia Pharma Announces Acceptance of Orviglance SPARKLE Study Primary Results as Oral Presentation in Cutting-Edge Research at the 2024 RSNA Annual Meeting

Regulatory

2024-09-30 | Change in Number of Shares and Votes in Ascelia Pharma AB

Regulatory

2024-09-13 | Ascelia Pharma Resolves on a Directed Issue of Convertibles of SEK 7.5 Million

Regulatory

2024-09-05 | Ascelia Pharma Announces Final Outcome in Fully Subscribed SEK 105 Million Rights Issue

Regulatory

2024-09-04 | Ascelia Pharma Announces Preliminary Outcome in Rights Issue

Regulatory

2024-08-16 | Ascelia Pharma Announces Prospectus in Connection with Rights Issue

Regulatory

2024-08-09 | Ascelia Pharma Announces Final Terms of Rights Issue

Regulatory

2024-07-10 | Ascelia Pharma Carries Out a Rights Issue of Units of Approximately SEK 105 Million to Fully Finance the NDA Submission for Orviglance®

Regulatory

2024-02-04 | Ascelia Pharma Secures Financing of up to SEK 35 Million

Regulatory

2023-11-30 | Change in Number of Shares and Votes in Ascelia Pharma AB

Regulatory

2023-02-28 | Change in number of shares and votes in Ascelia Pharma AB

Regulatory

2022-03-31 | Number of shares and votes in Ascelia Pharma AB

Regulatory

2021-04-30 | Number of shares and votes in Ascelia Pharma AB

Regulatory

2021-03-31 | Number of shares and votes in Ascelia Pharma AB

Regulatory

2021-03-17 | Ascelia Pharma has carried out a directed new share issue raising SEK 200 million

Regulatory

2021-03-17 | Ascelia Pharma intends to carry out a directed new share issue

2021-01-14 | Information regarding transfer of shares in Ascelia Pharma AB from CMC SPV

Regulatory

2020-07-31 | Change in number of shares and votes in Ascelia Pharma AB